FAQs
What is the primary role of a Senior Commercial Finance Analyst at Medpace?
The primary role is to partner with clients and internal staff to develop project financial budgets and new business proposals, ensuring alignment with both client needs and Medpace's objectives.
What qualifications are required for this position?
A Bachelor's Degree in Finance, Business, or Accounting is required, along with 3+ years of experience in clinical research or contract management/pricing.
What financial responsibilities does this role entail?
This role involves developing fee estimates for RFPs, budget revisions, reviewing proposal text assumptions, tracking ongoing project performance against budgets, and reviewing invoices and financial reports before they are sent to sponsors.
Are there opportunities for professional growth within Medpace?
Yes, Medpace offers structured career paths with opportunities for professional growth as part of its commitment to employee development.
What skills are emphasized for candidates applying for this position?
Candidates should have strong analytical, written and oral communication skills, along with excellent computer skills, particularly a strong knowledge of Microsoft Excel.
How does Medpace support work-life balance?
Medpace provides a flexible work environment and competitive PTO packages to support work-life balance for its employees.
Is knowledge of medical terminology necessary for this role?
Yes, a basic knowledge of medical terminology and an understanding of drug development services are desired for this role.
What types of clients will I be working with in this position?
You will be working with clients in the biotechnology, pharmaceutical, and medical device industries to develop strategic budgets and proposals.
What kind of benefits does Medpace offer to its employees?
Medpace provides a competitive compensation and benefits package, including employee appreciation events and health and wellness initiatives.
What recognition has Medpace received recently?
Medpace has been recognized by Forbes as one of America's Most Successful Midsize Companies in 2021, 2022, 2023, and 2024, and has received multiple CRO Leadership Awards from Life Science Leader magazine.